MMLRG - Overview: Antimicrobial Susceptibility, Acid-Fast Bacilli, Rapidly Growing, Varies
Determination of susceptibility of rapidly growing mycobacteria to the antimicrobial agents on the test panel
ACTHI - Overview: Adrenocorticotropic Hormone (ACTH) Immunostain, Technical Component Only
Aiding in the classification of pituitary adenomas and neoplasms with ectopic hormone production
B2MU - Overview: Beta-2 Microglobulin, Random, Urine
Evaluation of renal tubular damage Monitoring exposure to cadmium and mercury
BABG - Overview: Babesia microti IgG Antibodies, Serum
An adjunct in the diagnosis of babesiosis Follow-up of documented babesiosis
F_11 - Overview: Coagulation Factor XI Activity Assay, Plasma
Diagnosing deficiency of coagulation factor XI Investigating prolonged activated partial thromboplastin time
CARTA - Overview: Carbamazepine, Total, Serum
Monitoring therapy Determining compliance Assessing toxicity
CD21 - Overview: CD21 Immunostain, Technical Component Only
Identification of follicular dendritic cells and a subset of mantle zone lymphocytes
CK - Overview: Creatine Kinase (CK), Serum
Diagnosing and monitoring myopathies or other trauma, toxin, or drug-induced muscle injury
CNSA - Overview: Central Nervous System Consultation, Autopsy, Varies
Evaluation of congenital neurological disease Evaluation of neurodegenerative disease Evaluation of cases with a complex neurological or neurosurgical history Evaluation of sudden unexplained death This test is not intended for...
PDSU - Overview: Drug Screen, Prescription/Over the Counter, Random, Urine
Qualitative detection and identification of prescription or over-the-counter drugs frequently found in drug overdose or used with a suicidal intent Providing, when possible, the identification of all drugs in the specimen This test is not...
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Detection of (1→3)-𝝱-D-glucan as a Marker of Invasive Fungal Disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....